U.S. Capital Wealth Advisors LLC boosted its stake in Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI – Free Report) by 49.3% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 93,556 shares of the company’s stock after acquiring an additional 30,896 shares during the quarter. U.S. Capital Wealth Advisors LLC’s holdings in Counterpoint Quantitative Equity ETF were worth $3,695,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Avantax Advisory Services Inc. raised its position in Counterpoint Quantitative Equity ETF by 27.7% during the second quarter. Avantax Advisory Services Inc. now owns 56,600 shares of the company’s stock worth $2,105,000 after acquiring an additional 12,266 shares during the period. Concurrent Investment Advisors LLC purchased a new stake in shares of Counterpoint Quantitative Equity ETF during the second quarter worth about $1,700,000. Counterpoint Mutual Funds LLC acquired a new position in shares of Counterpoint Quantitative Equity ETF during the 2nd quarter worth about $46,070,000. Steward Partners Investment Advisory LLC raised its position in shares of Counterpoint Quantitative Equity ETF by 102.9% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 68,061 shares of the company’s stock worth $2,531,000 after purchasing an additional 34,518 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Counterpoint Quantitative Equity ETF in the 2nd quarter valued at about $1,121,000.
Counterpoint Quantitative Equity ETF Trading Up 1.1%
CPAI stock opened at $40.41 on Friday. Counterpoint Quantitative Equity ETF has a 12-month low of $28.48 and a 12-month high of $41.36. The business’s 50-day moving average is $39.57 and its 200 day moving average is $37.84. The stock has a market cap of $129.31 million, a price-to-earnings ratio of -48,453.24 and a beta of 1.25.
Counterpoint Quantitative Equity ETF Dividend Announcement
Counterpoint Quantitative Equity ETF Profile
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
See Also
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- What Does Downgrade Mean in Investing?
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- Stock Dividend Cuts Happen Are You Ready?
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- How to Profit From Growth Investing
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Want to see what other hedge funds are holding CPAI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Counterpoint Quantitative Equity ETF (NYSEARCA:CPAI – Free Report).
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
